DIPROSONE LOTION

国家: 加拿大

语言: 英文

来源: Health Canada

有效成分:

BETAMETHASONE (BETAMETHASONE DIPROPIONATE)

可用日期:

ORGANON CANADA INC.

ATC代码:

D07AC01

INN（国际名称）:

BETAMETHASONE

剂量:

0.05%

药物剂型:

LOTION

组成:

BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.05%

给药途径:

TOPICAL

每包单位数:

15G/50G

处方类型:

Prescription

治疗领域:

ANTI-INFLAMMATORY AGENTS

產品總結:

Active ingredient group (AIG) number: 0106299002; AHFS:

授权状态:

APPROVED

授权日期:

2011-02-08

产品特点

1
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
DIPROSONE
®
BETAMETHASONE DIPROPIONATE CREAM, ORGANON STANDARD,
0.05% W/W BETAMETHASONE (AS DIPROPIONATE)
BETAMETHASONE DIPROPIONATE OINTMENT, ORGANON STANDARD,
0.05% W/W BETAMETHASONE (AS DIPROPIONATE)
BETAMETHASONE DIPROPIONATE LOTION, USP,
0.05% W/W BETAMETHASONE (AS DIPROPIONATE)
Topical Corticosteroid
ORGANON CANADA INC.
16766 route Transcanadienne
Kirkland, Quebec
H9H 4M7
www.organon.ca
Date of Initial Approval:
NOV 07, 1974
Date of Revision:
April 7, 2021
Submission Control No.: 249884
2
TABLE OF CONTENTS
TABLE OF CONTENTS
..............................................................................................................2
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
1
INDICATIONS
..................................................................................................................3
1.1
Pediatrics
....................................................................................................................3
1.2
Geriatrics
....................................................................................................................3
2
CONTRAINDICATIONS
.................................................................................................3
3
DOSAGE AND ADMINISTRATION
.............................................................................3
3.1
Dosing Considerations
...............................................................................................3
3.2
Administration
...........................................................................................................4
4
MISSED DOSE
..................................................................................................................4
5
OVERDOSAGE
.................................................................................................................4
6
DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING ................4
7
WARNINGS AND PRECAUTIONS
.........